See also:
What is the most important information I should know about Chlorhexidine (Eye and Wound Powder)?
Chlorhexidine (Eye and Wound Powder) gluconate oral rinse should not be used by persons who are known to be hypersensitive to Chlorhexidine (Eye and Wound Powder) gluconate or other formula ingredients.
See also:
What is the most important information I should know about Hydrocortisone (Eye and Wound Powder)?
You should not use this medication if you are allergic to Hydrocortisone (Eye and Wound Powder), or if you have a fungal infection anywhere in your body.
Before taking Hydrocortisone (Eye and Wound Powder), tell your doctor about all of your medical conditions, and about all other medicines you are using. There are many other diseases that can be affected by steroid use, and many other medicines that can interact with steroids.
Your steroid medication needs may change if you have any unusual stress such as a serious illness, fever or infection, or if you have surgery or a medical emergency. Tell your doctor about any such situation that affects you during treatment.
Steroid medication can weaken your immune system, making it easier for you to get an infection or worsening an infection you already have or have recently had. Tell your doctor about any illness or infection you have had within the past several weeks.
Avoid being near people who are sick or have infections. Call your doctor for preventive treatment if you are exposed to chicken pox or measles. These conditions can be serious or even fatal in people who are using steroid medication.
Do not receive a "live" vaccine while you are taking Hydrocortisone (Eye and Wound Powder). Vaccines may not work as well while you are taking a steroid.
Do not stop using Hydrocortisone (Eye and Wound Powder) suddenly, or you could have unpleasant withdrawal symptoms. Talk to your doctor about how to avoid withdrawal symptoms when stopping the medication.
Carry an ID card or wear a medical alert bracelet stating that you are taking a steroid, in case of emergency.
Hypersensitivity to penicillins. Do not treat severe pneumonia, empyema, bacteremia, pericarditis, meningitis, and purulent or septic arthritis with oral Penicillin G (Eye and Wound Powder) during acute stage.
Sulphonamide sensitivity, kidney disease, glucose 6-phosphate deficiency (G6PD).
See also:
What are the possible side effects of Chlorhexidine (Eye and Wound Powder)?
The most common side effects associated with Chlorhexidine (Eye and Wound Powder) gluconate oral rinses are (1) an increase in staining of teeth and other oral surfaces, (2) an increase in calculus formation; and (3) an alteration in taste perception; see WARNINGS and PRECAUTIONS.
Oral irritation and local allergy-type symptoms have been spontaneously reported as side effects associated with the use of Chlorhexidine (Eye and Wound Powder) gluconate rinse.
The following oral mucosal side effects were reported during placebo-controlled adult clinical trials: aphthous ulcer, grossly obvious gingivitis, trauma, ulceration, erythema, desquamation, coated tongue, keratinization, geographic tongue, mucocele, and short frenum. Each occurred at a frequency of less than 1.0%.
Among post marketing reports, the most frequently reported oral mucosal symptoms associated with Chlorhexidine (Eye and Wound Powder) gluconate oral rinse are stomatitis, gingivitis, glossitis, ulcer, dry mouth, hypesthesia, glossal edema, and paresthesia.
Minor irritation and superficial desquamation of the oral mucosa have been noted in patients using Chlorhexidine (Eye and Wound Powder) gluconate oral rinse.
There have been cases of parotid gland swelling and inflammation of the salivary glands (sialadenitis) reported in patients using Chlorhexidine (Eye and Wound Powder) gluconate oral rinse.
See also:
What are the possible side effects of Hydrocortisone (Eye and Wound Powder)?
Applies to Hydrocortisone (Eye and Wound Powder) topical: topical application cream, topical application ointment
Other dosage forms:
In addition to its needed effects, some unwanted effects may be caused by Hydrocortisone (Eye and Wound Powder) topical (the active ingredient contained in Hydrocortisone (Eye and Wound Powder) with Aloe). In the event that any of these side effects do occur, they may require medical attention.
Major Side EffectsYou should check with your doctor immediately if any of these side effects occur when taking Hydrocortisone (Eye and Wound Powder) topical:
More common:
Some of the side effects that can occur with Hydrocortisone (Eye and Wound Powder) topical may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:
Less common:
See also:
What are the possible side effects of Penicillin G (Eye and Wound Powder)?
Phenoxymethylpenicillin may produce diarrhoea, nausea and heartburn. Allergic reactions which may include exfoliative dermatitis, other skin rashes, interstitial nephritis and vasculitis, may occur.
A generalised sensitivity reaction with urticaria, fever, joint pains and eosinophilia can develop within a few hours to several weeks after starting treatment. Superinfection by resistant species, such as Pseudomonas or Candida, which do not respond to penicillin therapy may occur. A sore mouth and a black hairy tongue have been reported.
Increases in liver enzyme values have been reported. Care should be taken when high doses are given to patients with renal impairment (because of the risk of neurotoxicity) or congestive heart failure.
Renal and haematological systems should be monitored during prolonged and high dose therapy.
Care should be taken when treating patients with syphilis, as the Jarisch-Herxheimer reaction may occur shortly after starting treatment. This reaction, manifesting as fever, chills, headache and reactions at the site of the lesion, can be dangerous in cardiovascular syphilis or where there is a serious risk of increased local damage such as with optic atrophy.
Haemolytic anaemia and leucopenia, prolongation of bleeding time and defective platelet function have been observed. Convulsions and other signs of toxicity to the CNS may occur particularly in patients with renal failure.
Disturbances of blood electrolytes may follow the administrations of large doses of this medicine.
High doses should be used with caution in patients receiving potassium containing medicines or potassium-sparing diuretics.
For local use of Chlorhexidine (Eye and Wound Powder) ICPA Health Products: trichomonas coleitis, cervical erosion, itching of the vulva, prevention of sexually transmitted diseases (including gonorrhea, syphilis, trichomoniasis, chlamydia, ureaplasmosis); gingivitis, stomatitis, aphthae, paradont, alveolitis, disinfection of removable dentures, sore throat; postoperative care for patients in ENT and dentistry.
Treatment of wounds, burn wounds and surfaces, disinfection of the patient's skin.
Treatment of surgeons', nurses' hands and operating field before diagnostic manipulation operation.
Disinfection of work surfaces of devices (including thermometers) and equipment which heat treatment is not desirable.
An indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, acetaminophen or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.When oral therapy is not feasible, and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intravenous or intramusculat use of Solu-Hydrocortisone (Eye and Wound Powder) Sterile Powder is indicated as follows:
Allergic states
Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions.
Dermatologic diseases
Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome).
Endocrine disorders
Primary or secondary adrenocortical insufficiency (Hydrocortisone (Eye and Wound Powder) or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis.
Gastrointestinal diseases
To tide the patient over a critical period of the disease in regional enteritis (systemic therapy) and ulcerative colitis.
Hematologic disorders
Acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia (Diamond Blackfan anemia), idiopathic thrombocytopenic purpura in adults (intravenous administration only; intramuscular administration is contraindicated), pure red cell aplasia, select cases of secondary thrombocytopenia.
Miscellaneous
Trichinosis with neurologic or myocardial involvement, tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy.
Neoplastic diseases
For the palliative management of leukemias and lymphomas.
Nervous System
Acute exacerbations of multiple sclerosis; cerebral edema associated with primary or metastatic brain tumor, or craniotomy.
Ophthalmic diseases
Sympathetic ophthalmia, uveitis and ocular inflammatory conditions unresponsive to topical corticosteroids.
Renal diseases
To induce diuresis or remission of proteinuria in idiopathic nephrotic syndrome, or that due to lupus erythematosus.
Respiratory diseases
Berylliosis, fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy, idiopathic eosinophilic pneumonias, symptomatic sarcoidosis.
Rheumatic disorders
As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis; acute rheumatic carditis; ankylosing spondylitis; psoriatic arthritis; rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy). For the treatment of dermatomyositis, temporal arteritis, polymyositis, and systemic lupus erythematosus.
An indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, acetaminophen or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.Prophylactic: Recurrence of rheumatic fever. Treatment of mild to moderate infections caused by sensitive organisms: Pneumococcal infections of the middle ear; Streptococcal otitis media and sinusitis; Streptococcal pharyngitis caused by Strep pyogenes; mild to moderate pulmonary and periodontal anaerobic infections; gingivostomatitis; early Lyme disease.
An indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, acetaminophen or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.Sulfathiazole (Eye and Wound Powder) is effective against a wide range of gram positive and gram negative pathogenic microorganisms. Although no longer used in humans, it is used in cattle.
Chlorhexidine (Eye and Wound Powder) is used to help treat periodontal disease (a disease of your gums), which is caused by bacteria growing beneath the gum line. Chlorhexidine (Eye and Wound Powder) works by killing the bacteria. Up to eight Chlorhexidine (Eye and Wound Powder) implants are placed between your teeth and gums in places where the gum has a deep pocket. Your dentist will place the Chlorhexidine (Eye and Wound Powder) implants after your teeth have been thoroughly cleaned.
Chlorhexidine (Eye and Wound Powder) is available only with your dentist's prescription.
See also: Entyvio
Hydrocortisone (Eye and Wound Powder) is a steroid medicine that is used in the treatment of many different conditions, including allergic disorders, skin conditions, ulcerative colitis, arthritis, lupus, multiple sclerosis, or lung disorders.
Hydrocortisone (Eye and Wound Powder) is also used to replace steroids in people with adrenal insufficiency (decreased production of natural steroids by the adrenal glands).
Hydrocortisone (Eye and Wound Powder) affects your immune system and is often used to treat certain blood cell disorders such as anemia (low red blood cells) or thrombocytopenia (low platelets).
Hydrocortisone (Eye and Wound Powder) is also used in the treatment of certain cancers such as leukemia, lymphoma, and multiple myeloma.
Hydrocortisone (Eye and Wound Powder) may also be used for purposes not listed in this medication guide.
Chlorhexidine (Eye and Wound Powder) mouthwash contains Chlorhexidine (Eye and Wound Powder) digluconate 1% v/v, equivalent to Chlorhexidine (Eye and Wound Powder) gluconate solution 0.2% w/v. It also contains ethanol, macrogolglycerol hydroxystearate, sorbitol, flavour and water.
Solu-Hydrocortisone (Eye and Wound Powder) 100 mg contains Hydrocortisone (Eye and Wound Powder) sodium succinate equivalent to Hydrocortisone (Eye and Wound Powder) 100 mg, monobasic sodium phosphate 1 mg, dibasic sodium 9 mg and sodium hydroxide 10%.
Solu-Hydrocortisone (Eye and Wound Powder) 100 mg/2 mL contains Hydrocortisone (Eye and Wound Powder) sodium succinate equivalent to Hydrocortisone (Eye and Wound Powder) 100 mg/2 mL, monobasic sodium phosphate 1 mg, dibasic sodium 10 mg and sodium hydroxide 10%.
Solu-Hydrocortisone (Eye and Wound Powder) 250 mg/2 mL contains Hydrocortisone (Eye and Wound Powder) sodium succinate equivalent to Hydrocortisone (Eye and Wound Powder) 250 mg/2 mL, monobasic sodium phosphate 2 mg, dibasic sodium phosphate 25 mg and sodium hydroxide 10%.
Solu-Hydrocortisone (Eye and Wound Powder) 500 mg/4 mL contains Hydrocortisone (Eye and Wound Powder) sodium succinate equivalent to Hydrocortisone (Eye and Wound Powder) 500 mg/4 mL, monobasic sodium phosphate 5 mg, dibasic sodium phosphate 52 mg and sodium hydroxide 10%.
Hydrocortisone (Eye and Wound Powder) sodium succinate or pregn-4-ene-3,20-dione,21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy; monosodium salt,(11β) is an anti-inflammatory adrenocortical steroid. This highly water-soluble sodium succinate ester of Hydrocortisone (Eye and Wound Powder) permits the immediate IV administration of high doses of Hydrocortisone (Eye and Wound Powder) in a small volume of diluent and is particularly useful where high blood levels of Hydrocortisone (Eye and Wound Powder) are required rapidly.
When necessary, the pH of Solu-Hydrocortisone (Eye and Wound Powder) was adjusted with sodium hydroxide so that the pH of the reconstituted solution is within the USP specified range of 7-8.
A penicillin derivative commonly used in the form of its sodium or potassium salts in the treatment of a variety of infections. It is effective against most gram-positive bacteria and against gram-negative cocci. It has also been used as an experimental convulsant because of its actions on gamma-aminobutyric acid mediated synaptic transmission.
Sulfathiazole (Eye and Wound Powder) is a short-acting sulfa drug. It used to be a common oral and topical antimicrobial until less toxic alternatives were discovered. It is still occasionally used, sometimes in combination with sulfabenzamide and sulfacetamide.
Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.
Do not take by mouth. Chlorhexidine (Eye and Wound Powder) topical is for use only on the skin.
Rinse the skin before applying Chlorhexidine (Eye and Wound Powder) topical. Apply only enough medicine to cover the area you are treating. Do not apply this medicine to deep cuts, scrapes, or open skin wounds.
To use Chlorhexidine (Eye and Wound Powder) topical soap, apply only enough to cover the area you are treating. Wash the area gently, then rinse thoroughly with plain water. Avoid using over large areas of skin.
This medicine is made under sterile conditions, but its contents are not sterilized. It is possible for bacteria to get inside the product and contaminate it, which could spread infection. To avoid contaminating your medicine with bacteria:
Use only the swab, pad, or applicator provided with your medicine.
If no applicator is provided, use only a clean cotton ball or cotton swab to apply this medicine.
Do not touch the tip of the medicine bottle with your fingers or touch it to your skin.
Do not dilute the medicine with water or other liquid.
Use the applicator (pad, swab, or other dressing) only once. Throw away after one use.
Call your doctor if your symptoms do not improve, or if they get worse while using Chlorhexidine (Eye and Wound Powder) topical.
Store at room temperature away from moisture and heat. Do not freeze. Keep the bottle tightly closed when not in use.
If this medicine is packaged in a single-use foil wrapper or other container, use it only once. Throw away after one use, even if there is still medicine left in it. Do not save for later use.
Use Hydrocortisone (Eye and Wound Powder) solution as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Hydrocortisone (Eye and Wound Powder) solution.
There are specific as well as general uses of a drug or medicine. A medicine can be used to prevent a disease, treat a disease over a period or cure a disease. It can also be used to treat the particular symptom of the disease. The drug use depends on the form the patient takes it. It may be more useful in injection form or sometimes in tablet form. The drug can be used for a single troubling symptom or a life-threatening condition. While some medications can be stopped after few days, some drugs need to be continued for prolonged period to get the benefit from it.Garlic has been used for hardening of the arteries (atherosclerosis) and high blood pressure (hypertension). Consult your doctor for more information if you have heart disease or high blood pressure. Garlic has also been used to prevent tick bites.
Some herbal/dietary supplement products have been found to contain possibly harmful impurities/additives. Check with your pharmacist for more details about the brand you use.
The FDA has not reviewed this product for safety or effectiveness. Consult your doctor or pharmacist for more details.
How to use Chlorhexidine (Eye and Wound Powder)Take this product by mouth as directed. Follow all directions on the product package. If you are uncertain about any of the information, consult your doctor or pharmacist.
If your condition persists or worsens, or if you think you may have a serious medical problem, seek immediate medical attention.
There are specific as well as general uses of a drug or medicine. A medicine can be used to prevent a disease, treat a disease over a period or cure a disease. It can also be used to treat the particular symptom of the disease. The drug use depends on the form the patient takes it. It may be more useful in injection form or sometimes in tablet form. The drug can be used for a single troubling symptom or a life-threatening condition. While some medications can be stopped after few days, some drugs need to be continued for prolonged period to get the benefit from it.Hydrocortisone (Eye and Wound Powder) is a natural substance (corticosteroid hormone) made by the adrenal gland. It is used to treat conditions such as arthritis, blood/hormone/immune system disorders, skin and eye conditions, breathing problems, cancer, and severe allergies. It decreases your immune system's response to various diseases to reduce symptoms such as pain, swelling and allergic-type reactions.
Hydrocortisone (Eye and Wound Powder) is also used to treat low Hydrocortisone (Eye and Wound Powder) levels caused by diseases of the adrenal gland (such as Addison's disease, adrenocortical insufficiency). Corticosteroids are needed in many ways for the body to function well. They are important for salt and water balance and keeping blood pressure normal.
How to use Hydrocortisone (Eye and Wound Powder)Take this medication by mouth, with food or milk to prevent stomach upset, exactly as directed by your doctor. Take this medication with a full glass of water (8 ounces/240 milliliters) unless your doctor directs you otherwise.
Follow the dosing schedule carefully. The dosage and length of treatment are based on your medical condition and response to treatment. Your doctor may direct you to take Hydrocortisone (Eye and Wound Powder) 1 to 4 times a day or take a single dose every other day. It may help to mark your calendar with reminders or use a pill box.
Do not stop taking this medication without consulting your doctor. Some conditions may become worse when this drug is suddenly stopped. Your dose may need to be gradually decreased.
If you have used Hydrocortisone (Eye and Wound Powder) regularly for a long time or in high doses, you may have withdrawal symptoms if the drug is suddenly stopped. To prevent withdrawal symptoms (such as weakness, weight loss, nausea, muscle pain, headache, tiredness, dizziness), your doctor may reduce your dose gradually. Consult your doctor or pharmacist for more details, and report any withdrawal reactions right away. See also Precautions section.
Tell your doctor if your condition persists or worsens.
There are specific as well as general uses of a drug or medicine. A medicine can be used to prevent a disease, treat a disease over a period or cure a disease. It can also be used to treat the particular symptom of the disease. The drug use depends on the form the patient takes it. It may be more useful in injection form or sometimes in tablet form. The drug can be used for a single troubling symptom or a life-threatening condition. While some medications can be stopped after few days, some drugs need to be continued for prolonged period to get the benefit from it.Penicillin G (Eye and Wound Powder) (also known as benzyl penicillin) is used:
15 mL twice daily after brushing.
Oral rinse should be retained for 30 seconds then expectorated after rinsing.
Usual Adult Dose for Mucositis
15 mL twice daily after brushing.
Oral rinse should be retained for 30 seconds then expectorated after rinsing.
Usual Adult Dose for Periodontitis
Initial: One 2.5 mg chip inserted into a periodontal pocket with probing pocket depth greater than or equal to 5 mm, up to 8 chips in one visit.
Maintenance: Administration is recommended once every 3 months in pockets with remaining probing depth greater than or equal to 5 mm.
Usual Adult Dose for Skin Disinfection, Preoperative
Chlorhexidine (Eye and Wound Powder) gluconate 2% cloth:
Patient preoperative skin preparation:
Hold package in one hand and lift flap on backside of package with the other hand. Grasp flap at top and pull down to tear flap away and expose foam. Alternatively, using sterile scissors, cut off end seal of package. Transfer contents onto prep table, avoiding contact between cloths and outside of package to reduce risk of cloth contamination. Use the first cloth to prepare the skin area indicated for a moist or dry site, making certain to keep the second cloth where it will not be contaminated. Use the second cloth to prepare larger areas.
DRY SURGICAL SITES: (such as the abdomen or arm): Use one cloth to cleanse each 161 cm2 area (approximately 5 x 5 inches) of skin to be prepared. Vigorously scrub skin back and forth for 3 minutes, completely wetting treatment area, then discard. Allow area to air dry for one minute. Do not rinse.
MOIST SURGICAL SITES: (such as the inguinal fold): Use one cloth to cleanse each 65 cm2 area (approximately 2 x 5 inches) of skin to be prepared. Vigorously scrub skin back and forth for 3 minutes, completely wetting treatment area, then discard. Do not rinse.
Chlorhexidine (Eye and Wound Powder) gluconate 4% solution:
SURGICAL HAND SCRUB: Do not dilute. Wet hands and forearms with water and scrub for 3 minutes with about 5 ml and a wet brush, paying close attention to the nails, cuticles, and interdigital spaces. Wash for an additional 3 minutes with 5 ml and rinse under running water. Dry thoroughly.
HEALTHCARE PERSONNEL HANDWASH: Do not dilute. Wet hands with water. Dispense about 5 ml into cupped hands and wash in a vigorous manner for 15 seconds. Rinse and dry thoroughly.
PATIENT PREOPERATIVE SKIN PREPARATION: Do not dilute. Apply liberally to surgical site and swab for at least 2 minutes. Dry with a sterile towel. Repeat procedure for an additional 2 minutes and dry with a sterile towel.
SKIN WOUND AND GENERAL SKIN CLEANSING: Do not dilute. Thoroughly rinse the area to be cleaned with water. Apply a minimum amount necessary to cover the skin or would area and wash gently. Rinse again thoroughly.
Usual Pediatric Dose for Gingivitis
The safety and efficacy of Chlorhexidine (Eye and Wound Powder) gluconate has not been established in patients less than 18 years old. However, the use of Chlorhexidine (Eye and Wound Powder) gluconate may be appropriate in some situations.
15 mL twice daily after brushing.
Oral rinse should be retained for 30 seconds then expectorated after rinsing.
Usual Pediatric Dose for Mucositis
The safety and efficacy of Chlorhexidine (Eye and Wound Powder) gluconate has not been established in patients less than 18 years old. However, the use of Chlorhexidine (Eye and Wound Powder) gluconate may be appropriate in some situations.
15 mL twice daily after brushing.
Oral rinse should be retained for 30 seconds then expectorated after rinsing.
Usual Pediatric Dose for Periodontitis
The safety and efficacy of Chlorhexidine (Eye and Wound Powder) gluconate has not been established in patients less than 18 years old. However, the use of Chlorhexidine (Eye and Wound Powder) gluconate may be appropriate in some situations.
Initial: One 2.5 mg chip inserted into a periodontal pocket with probing pocket depth greater than or equal to 5 mm, up to 8 chips in one visit.
Maintenance: Administration is recommended once every 3 months in pockets with remaining probing depth greater than or equal to 5 mm.
Renal Dose Adjustments
No adjustment recommended
Liver Dose Adjustments
No adjustment recommended
Dialysis
No adjustment recommended
Other Comments
Chlorhexidine (Eye and Wound Powder) topical cloths are not sterile.
Chlorhexidine (Eye and Wound Powder) topical cloths should not be microwaved.
Chlorhexidine (Eye and Wound Powder) solution should be used with care in premature infants or infants under 2 months of age. These products may cause irritation or chemical burns.
Chlorhexidine (Eye and Wound Powder) topical cloths should not be used in premature or low birthweight infants, infants receiving phototherapy, or infants less than 2 months of age. Chlorhexidine (Eye and Wound Powder) topical cloths and Chlorhexidine (Eye and Wound Powder) 4% solution should not be used for lumbar punctures or in contact with the meninges, or on open wounds or as a general skin cleanser.
Chlorhexidine (Eye and Wound Powder) topical cloths and Chlorhexidine (Eye and Wound Powder) 4% solution should not make contact with the eyes, nose, or mouth. If contact occurs, the affected area should be washed with cold water and a doctor should be contacted.
Chlorhexidine (Eye and Wound Powder) 4% solution should not be diluted.
Repeated general cleansing of large areas of the body with Chlorhexidine (Eye and Wound Powder) 4% topical solution should be avoided except when the underlying condition makes it necessary to reduce the bacterial population of the skin.
The initial dosage of Hydrocortisone (Eye and Wound Powder) Tablets may vary from 20 mg to 240 mg of Hydrocortisone (Eye and Wound Powder) per day depending on the specific disease entity being treated. In situations of less severity lower doses will generally suffice while in selected patients higher initial doses may be required. The initial dosage should be maintained or adjusted until a satisfactory response is noted. If after a reasonable period of time there is a lack of satisfactory clinical response, Hydrocortisone (Eye and Wound Powder) should be discontinued and the patient transferred to other appropriate therapy. IT SHOULD BE EMPHASIZED THAT DOSAGE REQUIREMENTS ARE VARIABLE AND MUST BE INDIVIDUALIZED ON THE BASIS OF THE DISEASE UNDER TREATMENT AND THE RESPONSE OF THE PATIENT. After a favorable response is noted, the proper maintenance dosage should be determined by decreasing the initial drug dosage in small decrements at appropriate time intervals until the lowest dosage which will maintain an adequate clinical response is reached. It should be kept in mind that constant monitoring is needed in regard to drug dosage. Included in the situations which may make dosage adjustments necessary are changes in clinical status secondary to remissions or exacerbations in the disease process, the patient's individual drug responsiveness, and the effect of patient exposure to stressful situations not directly related to the disease entity under treatment; in this latter situation it may be necessary to increase the dosage of Hydrocortisone (Eye and Wound Powder) for a period of time consistent with the patient's condition. If after long-term therapy the drug is to be stopped, it is recommended that it be withdrawn gradually, rather than abruptly.
Multiple SclerosisIn treatment of acute exacerbations of multiple sclerosis, daily doses of 200 mg of prednisolone for a week followed by 80 mg every other day for 1 month have been shown to be effective (20 mg of Hydrocortisone (Eye and Wound Powder) is equivalent to 5 mg of prednisolone).
How suppliedHydrocortisone (Eye and Wound Powder) Tablets are available in the following strengths and package sizes:
5 mg (white, round, scored, imprinted Hydrocortisone (Eye and Wound Powder) 5) Bottles of 50 NDC 0009-0012-01
10 mg (white, round, scored, imprinted Hydrocortisone (Eye and Wound Powder) 10) Bottles of 100 NDC 0009-0031-01
20 mg (white, round, scored, imprinted Hydrocortisone (Eye and Wound Powder) 20) Bottles of 100 NDC 0009-0044-01
Store at controlled room temperature 20° to 25°C (68° to 77°F).
Distributed by: Pharmacia & Upjohn Company, Division of Pfizer Inc., NY, NY 10017. Revised: Sep 2013
Adult : Vag Per g cream contains Sulfathiazole (Eye and Wound Powder) 34.2 mg, sulphacetamide 28.6 mg, sulphabenzamide 37 mg and urea 6.4 mg: Apply 5 g twice daily for 4-6 days. Thereafter, reduce dosage to one-half or one-quarter.
See also:
What other drugs will affect Chlorhexidine (Eye and Wound Powder)?
Chlorhexidine (Eye and Wound Powder) is incompatible with the soap, and detergents containing anionic group (saponins, sodium lauryl sulfate, sodium carboxymethyl cellulose).
Chlorhexidine (Eye and Wound Powder) ICPA Health Products is compatible with any medication containing cationic group (cetrimonium bromide, benzalkonium chloride).
See also:
What other drugs will affect Hydrocortisone (Eye and Wound Powder)?
With simultaneous use of Hydrocortisone (Eye and Wound Powder) increases the toxicity of cardiac glycosides (because of the emerging hypokalemia increases the risk of arrhythmias); with acetylsalicylic acid - accelerates its excretion and reduces its concentration in blood plasma (with the abolition of Hydrocortisone (Eye and Wound Powder) concentration of salicylates in the blood increases, and increases the risk of side effects); with paracetamol - increased risk of hepatotoxic action of paracetamol (induction of hepatic enzymes and formation of a toxic metabolite of paracetamol); with cyclosporine - increased side effects of Hydrocortisone (Eye and Wound Powder) as a result of inhibition of its metabolism; with ketoconazole - increased side effects of Hydrocortisone (Eye and Wound Powder) as a result of reduction of its clearance.
Hydrocortisone (Eye and Wound Powder) Micronised Xepa-Soul Pattinson reduces the effectiveness of hypoglycemic; intensifies the effect of indirect anticoagulants of coumarin derivatives.
Hydrocortisone (Eye and Wound Powder) reduces the effect of vitamin D on the absorption of calcium ions into the lumen of the intestine. Ergocalciferol and parathyroid hormone hinder the development of osteopathy caused by GCS.
Hydrocortisone (Eye and Wound Powder) Micronised Xepa-Soul Pattinson increases the metabolism of isoniazid, meksiletina (especially in "fast acetylators"), which leads to a decrease in their plasma concentrations; increases (with prolonged therapy) the content of folic acid reduces the concentration of praziquantel in blood.
Hydrocortisone (Eye and Wound Powder) in high doses reduces the effect somatropina.
Hypokalemia caused by GCS, may increase the severity and duration of muscle blockade on the background of muscle relaxants.
Antacids reduce the absorption of the GCS.
At simultaneous application with SCS thiazides, carbonic anhydrase inhibitors, other GCS, amphotericin B increase the risk of hypokalemia, drugs containing sodium ions - swelling and increase blood pressure.
NSAIDs and ethanol increases the risk of gastrointestinal ulcerations and bleeding, in combination with NSAIDs to treat arthritis may reduce the dose of GCS due to summation of therapeutic effect. Indomethacin displacing the SCS from its association with albumin, increases the risk of its side effects.
Amphotericin B and carbonic anhydrase inhibitors increase the risk of osteoporosis.
The therapeutic effect of GCS is reduced under the influence of inducers of microsomal liver enzymes (including phenytoin, barbiturates, ephedrine, theophylline, rifampin) due to increased rate of metabolism of these substances.
Inhibitors of the function of the adrenal cortex (including mitotan) may necessitate higher doses of GCS.
Clearance GCS increased against the background of preparations of thyroid hormones.
Immunosuppressants increase the risk of infection and lymphoma or other lymphoproliferative disorders associated with Epstein-Barr virus.
Estrogens (including oral contraceptives containing estrogen) reduce the clearance of GKS, lengthens T1/2 and their therapeutic and toxic effects. The appearance of hirsutism and acne promotes the simultaneous use of other steroid hormone funds - androgens, estrogens, anabolic steroids, oral contraceptives.
Tricyclic antidepressants may increase the severity of depression caused by GCS (not shown for the treatment of these side effects).
The risk of developing cataracts increases with the application against other GCS antipsychotic funds (neuroleptics), carbutamide and azathioprine. Simultaneous of Hydrocortisone (Eye and Wound Powder) Micronised Xepa-Soul Pattinson with the appointment of m-cholinoblockers, as well as with means having m-anticholinergic action (including antihistamines, tricyclic antidepressants), with nitrates improves the intraocular pressure.
With simultaneous application of SCS with live vaccines and antiviral compared to other types of immunization increases the risk of activation of viruses and development of infections.
Anticoagulants (oral and heparin)
May increase bleeding risks of anticoagulant by prolonging bleeding time.
Beta-blockers
May potentiate anaphylactic reactions of penicillin.
Chloramphenicol
May cause synergism or antagonism to develop.
Contraceptives, oral
May reduce efficacy of oral contraceptives.
Erythromycin
May cause synergism or antagonism to develop.
Probenecid
Increases penicillin serum concentration.
Tetracyclines
May impair bactericidal effects of Penicillin G (Eye and Wound Powder).
Incompatibility
Aminoglycosides, parenteral
Penicillin may inactivate aminoglycosides in vitro; do not mix in same IV solution. May be used in combination for synergy if administered separately.
Carbohydrate solutions at alkaline pH
Penicillin solutions are rapidly inactivated.
Laboratory Test Interactions
Antiglobulin (Coombs test)
Drug may cause false-positive results.
Urine glucose test
Drug may cause false-positive results with copper sulfate tests (Benedict test, Fehling test, or Clinitest tablets); enzyme-based tests (eg, Clinistix, Tes-tape ) are not affected.
Urine protein determinations
Drug may cause false-positive reactions with sulfosalicylic acid and boiling test, acetic acid test, biuret reaction, and nitric acid test; bromphenol blue test ( Multi-Stix ) is not affected.
